CRL · 10-Q · 2026Q2 · Full report
Operating Cash Flow Trends
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 64 · Surprise 56 · From source text
Six-month operating cash flow decreased 41.3% to $220.8 million from $376.3 million in the prior-year period. The decline primarily reflected higher annual incentive bonus payments made in the first quarter and higher acquisition, integration, and divestiture-related payments. Net income shifted from $78.6 million of income to a $15.6 million loss, while operating adjustments increased to $342.6 million from $285.3 million. Cash used in investing activities increased to $379.7 million, driven by $467.3 million of acquisitions and $87.0 million of capital expenditures, partly offset by $176.6 million of divestiture and asset-sale proceeds.
Key facts
- Net cash provided by operating activities for the six months ended June 27, 2026: $220.8 million, compared with $376.3 million for the same period in 2025. source
- Decrease in operating cash flow was primarily related to higher payments of variable compensation (annual incentive bonuses) and higher acquisition, integration and divestiture-related payments. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -2.1% | Net cash provided by operating activities for the six months ended June 27, 2026: $220.8 million, compared with $376.3 million for the… |